Computational development of mushroom-6-glucan/paclitaxel as a synergistic complementary medicine for breast cancer therapy
Our study revealed that the computationally predicted 6-glucans-based binary complementary medicine exhibited sequence- and concentration-dependent anticancer synergistic effects.
Authors
- A. Kamel (ORCID: https://orcid.org/0000-0002-5068-5445)
- Ahmed M. Kenawy (ORCID: https://orcid.org/0000-0001-5243-2532)
- Nehal M. El‐Deeb (ORCID: https://orcid.org/0000-0002-8561-9456)
- Omar M. Ibrahim (ORCID: https://orcid.org/0000-0002-9903-6657)
- A.I. Gomaa
Institutions
- James S. McDonnell Foundation (US)
- University of Ottawa (CA)
- Washington University in St. Louis (US)
- City of Scientific Research and Technological Applications (EG)
- National Research Centre (EG)
Publication Details
- Journal
- BMC Complementary Medicine and Therapies
- Published
- 2025-02-15
- DOI
- https://doi.org/10.1186/s12906-025-04772-7
- Primary Topic
- Cancer Cells and Metastasis
- Type
- article
- Field-Weighted Citation Impact
- 0.00